
Article 1 
Annexes I, II and III to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.
Article 2 
This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Brussels, 24 September 1997.
For the Commission
Martin BANGEMANN
Member of the Commission
ANNEX

The Annexes to Regulation (EEC) No 2377/90 are hereby amended as follows:

A.. Annex I is amended as follows:

2.. Antiparasitic agents

2.1. Agents acting against endoparasites

2.1.3. Benzimidazoles and pro-benzoimidazoles

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions

‘2.1.3.1. Febantel
 Sum of extractable residues which may be oxidized to oxfendazole sulphone Bovine, ovine, porcine, equidae 50 μg/kg Muscle 
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
Bovine, ovine 10 μg/kg Milk

2.1.3.2. Fenbendazole
 Sum of extractable residues which may be oxidized to oxfendazole sulphone Bovine, ovine, porcine, equidae 50 μg/kg Muscle 
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
Bovine, ovine 10 μg/kg Milk

2.1.3.3. Oxfendazole
 Sum of extractable residues which may be oxidized to oxfendazole sulphone Bovine, ovine, porcine, equidae 50 μg/kg Muscle 
50 μg/kg Fat
500 μg/kg Liver
50 μg/kg Kidney
Bovine, ovine 10 μg/kg Milk’
5.. Corticoids

5.1. Glucocorticoids

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions

‘5.1.1. Dexamethasone
 Dexamethasone Bovine, porcine, equidae 0,75 μg/kg Muscle 
2,0 μg/kg Liver
0,75 μg/kg Kidney
Bovine 0,3 μg/kg Milk’
B.. Annex II is amended as follows:

1.. Inorganic compounds

Pharmacologically active substance(s) Animal species Other provisions

‘1.29. Bromide, sodium salt
 All food producing mammals For topical use only’
C.. Annex III is amended as follows:

1.. Anti-infectious agents

1.2. Antibiotics

1.2.4. Cephalosporins

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions

‘1.2.4.1. Ceftiofur
 Sum of all residues retaining the betalactam structure expressed as desfuroylceftiofur Bovine 2 000 μg/kg Liver, kidney 200 μg/kg
Muscle 600 μg/kg
Fat 100 μg/kg
Milk Provisional MRLs expire on 1. 1. 1999’
Porcine 4 000 μg/kg Kidney
3 000 μg/kg Liver
500 μg/kg Muscle
600 μg/kg Fat
1.2.6. Quinolones

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions

‘1.2.6.1. Danofloxacin
 Danofloxacin Bovine 900 μg/kg Liver 500 μg/kg
Kidney 300 μg/kg
Muscle 200 μg/kg
Fat Provisional MRLs expire on 1. 1. 1999’
Chicken 1 200 μg/kg Liver, kidney
600 μg/kg Skin + fat
300 μg/kg Muscle
2.. Antiparasitic agents

2.1. Agents acting against endo-parasites

2.1.1. Benzimidazoles and pro-benzoimidazoles

Pharmacologically active substance Marker residue Animal species MRLs Target tissues Other provisions

‘2.1.1.9. Netobimin
 Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino-benzimidazole sulphone Bovine, ovine, caprine 100 μg/kg Muscle, fat Provisional MRLs expire on 31. 7. 1999’
1 000 μg/kg Liver
500 μg/kg Kidney
100 μg/kg Milk
